Influenza
Showing NaN - NaN of 58
SARS-CoV-2, Influenza Trial in Canada, United States (mRNA-1083, Placebo, Influenza Vaccine)
Not yet recruiting
- SARS-CoV-2
- Influenza
- mRNA-1083
- +3 more
-
Anniston, Alabama
- +172 more
Oct 18, 2023
Influenza Trial in United States (mRNA-1010, mRNA-1010.4, mRNA-1010.6)
Recruiting
- Influenza
- mRNA-1010
- +2 more
-
Hollywood, Florida
- +9 more
May 11, 2023
SARS-CoV-2, Influenza Trial in United States (Fluarix, mRNA-1083.1, mRNA-1083.2)
Recruiting
- SARS-CoV-2
- Influenza
- Fluarix
- +8 more
-
Chandler, Arizona
- +68 more
Apr 24, 2023
Influenza, Influenza -Like Illness Trial in United States (Norketotifen, Placebo)
Completed
- Influenza
- Influenza -Like Illness
- Norketotifen
- Placebo
-
Phoenix, Arizona
- +19 more
Jan 25, 2023
Influenza Trial in Worldwide (Baloxavir Marboxil, Placebo)
Recruiting
- Influenza
- Baloxavir Marboxil
- Placebo
-
Birmingham, Alabama
- +290 more
Jan 20, 2023
Influenza Trial in United States (Quadrivalent influenza vaccine, high-dose, Quadrivalent influenza vaccine, standard dose)
Suspended
- Influenza
- Quadrivalent influenza vaccine, high-dose
- Quadrivalent influenza vaccine, standard dose
-
San Diego, California
- +9 more
May 3, 2022
Influenza Trial in Canada, United States (High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 µg (split-virion, inactivated),
Completed
- Influenza
- High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 μg (split-virion, inactivated)
- +4 more
-
San Diego, California
- +15 more
Mar 24, 2022
Influenza Trial in United Kingdom, United States (Fluzone Quadrivalent vaccine, No Preservative)
Completed
- Influenza
- Fluzone Quadrivalent vaccine, No Preservative
-
Birmingham, Alabama
- +35 more
Mar 15, 2022
HIV, Influenza Trial in Puerto Rico, United States (Cold-adapted live attenuated influenza vaccine (FluMist), Inactivated
Completed
- HIV Infections
- Influenza
- Cold-adapted live attenuated influenza vaccine (FluMist)
- Inactivated influenza vaccine (IAIV)
-
Birmingham, Alabama
- +60 more
Oct 28, 2021
Influenza Trial in Worldwide (Liquid CAIV-T)
Completed
- Influenza
- Liquid CAIV-T
-
Hoover, Alabama
- +160 more
Sep 10, 2021
Influenza Trial in Miami (VAL-339851, Placebo)
Completed
- Influenza
- VAL-339851
- Placebo
-
Miami, FloridaMiami Research Associates
Jan 7, 2021
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine
Completed
- Pregnancy
- Influenza
- Quadrivalent Intradermal Influenza Vaccine (QIV)
-
San Diego, California
- +4 more
Feb 11, 2020
Influenza Trial in Worldwide (Amantadine, Ribavirin, Oseltamivir, Oseltamivir)
Completed
- Influenza
- Amantadine, Ribavirin, Oseltamivir
- Oseltamivir
-
Birmingham, Alabama
- +90 more
Jan 31, 2019
Influenza Trial in Worldwide (Influenza vaccine GSK2321138A, FluarixTM, Influenza vaccine GSK2604409A)
Completed
- Influenza
- Influenza vaccine GSK2321138A
- +2 more
-
Chandler, Arizona
- +41 more
Aug 22, 2018
Influenza Trial in Canada, United States (GSK A/turkey H5N1 Influenza vaccine)
Completed
- Influenza
- GSK A/turkey H5N1 Influenza vaccine
-
Huntsville, Alabama
- +9 more
Aug 22, 2018
Influenza Trial in Worldwide (Trivalent influenza vaccine (TIVc), Trivalent influenza vaccine-licensed)
Completed
- Influenza
- Trivalent influenza vaccine (TIVc)
- Trivalent influenza vaccine-licensed
-
Phoenix, Arizona
- +26 more
Jun 11, 2018
Influenza Trial in Canada, United States (Investigational H9N2 vaccine GSK2654911A, Investigational H9N2 vaccine GSK2654909A,
Completed
- Influenza
- Investigational H9N2 vaccine GSK2654911A
- +2 more
-
Miami, Florida
- +3 more
Jun 14, 2018
Influenza Trial in Miami, Lenexa (Trivalent influenza vaccine GSK 138842A, Fluarix)
Completed
- Influenza
- Trivalent influenza vaccine GSK 138842A
- Fluarix
-
Miami, Florida
- +1 more
May 9, 2018
Influenza Trial in Canada, United States (Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, Placebo)
Completed
- Influenza
- Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
- Placebo
-
Huntsville, Alabama
- +39 more
May 9, 2018